ProCE Banner Activity

CE

Medical Minute 2: Holistic MS Management

Multimedia
Hear expert faculty discuss the most important considerations when starting or stopping disease modifying therapies in patients with MS.
Registered Nurses AANP : 0.67 AANP contact {hour}

Released: August 01, 2020

Expiration: August 01, 2021

No longer available for credit.

Share

Faculty

Lisa Aquillano

Lisa Aquillano, PharmD, BCPS, MSCS

Clinical Pharmacy Specialist
Multiple Sclerosis
Emory University Hospital

Calli Cook

Calli Cook, DNP, APRN, FNP-C, FAANP

Clinical Assistant Professor
Emory University, NHWSON
Nurse Practitioner
Emory Brain Health Center
Atlanta, Georgia

Provided by

Provided by the American Association of Nurse Practitioners (AANP)
ProCE Banner

Supporters

Supported by educational grants from

Biogen

Genentech, a member of the Roche Group

Novartis Pharmaceuticals Corporation

Sanofi Genzyme Corp

Target Audience

This initiative is intended for NPs involved in managing patients with multiple sclerosis (MS).

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Utilize currently available agents to initiate and modify MS therapy in accordance with the most recent guidelines and evidence.

Faculty Disclosure

Primary Author

Lisa Aquillano, PharmD, BCPS, MSCS

Clinical Pharmacy Specialist
Multiple Sclerosis
Emory University Hospital

Lisa Aquillano, PharmD, BCPS, MSCS has no relevant conflicts of interest to report.

Calli Cook, DNP, APRN, FNP-C, FAANP

Clinical Assistant Professor
Emory University, NHWSON
Nurse Practitioner
Emory Brain Health Center
Atlanta, Georgia

Calli Cook, DNP, APRN, FNP-C, FAANP has no relevant conflicts of interest to report.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Anne Roc, PhD

Director, Scientific Services

Anne Roc, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Instructions for Credit

CE Statement

This activity is approved for 0.67 contact hours of continuing education (which includes 0.67 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID# 1137-1141-1144-1145. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Additional Information

Program Medium

This program has been made available online.


Goal


The goal of these educational activities is to improve knowledge and competence among NPs in diagnosing and managing MS in a primary care setting.